TCBWMS
CUE icon

Texas Capital Bank Wealth Management Services’s Cue Biopharma CUE Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$91.4K Sell
13,247
-1,442
-10% -$13.5K 0.01% 338
2025
Q4 		$135K Buy
14,689
+13,586
+1,232% +$250K 0.01% 327
2025
Q3 		$23.8K Hold
1,103
– – ﹤0.01% 254
2025
Q2 		$22.6K Hold
1,103
– – ﹤0.01% 222
2025
Q1 		$30.2K Hold
1,103
– – ﹤0.01% 207
2024
Q4 		$36.1K Buy
+1,103
New +$41.5K ﹤0.01% 160

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $1.84B AUM 19.34% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

Texas Capital Bank Wealth Management Services's CUE Position: Q1 2026 in Review

Texas Capital Bank Wealth Management Services reduced its Cue Biopharma (CUE) stake by 9.8% in Q1 2026, selling an estimated $13.5K and leaving 13,247 shares worth $91.4K. The position accounts for 0.01% of the portfolio, ranked #338.

Texas Capital Bank Wealth Management Services first reported a position in CUE in Q4 2024 and has held it in 6 quarters since. The position peaked at $135K in Q4 2025. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • Texas Capital Bank Wealth Management Services held 13,247 shares of Cue Biopharma worth $91.4K as of Q1 2026.
  • Texas Capital Bank Wealth Management Services sold 1,442 Cue Biopharma shares in Q1 2026, an estimated $13.5K.
  • Cue Biopharma made up 0.01% of Texas Capital Bank Wealth Management Services's portfolio in Q1 2026, its #338 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in Cue Biopharma in Q4 2024 and has held it in 6 quarters since.
  • Texas Capital Bank Wealth Management Services's Cue Biopharma position peaked at $135K in Q4 2025.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q1 2026, filed 11 May 2026.